Testing effectiveness (Phase 2)Study completedNCT01063907
What this trial is testing
KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Who this might be right for
Multiple Myeloma
Kyowa Kirin Co., Ltd. 95